Immunotherapy for the Treatment of Advanced Solid Tumor

Clinical trial NCT03658785 · RECRUITING

Trial details

NCT number: NCT03658785
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrence Tumor Metastatic Cancer Solid Tumor

Start date: 2020-04-28
Primary completion: 2024-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.